Excretion of radiolabelled AZD0837
Study identifier:D1250C00032
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open, single centre pharmacokinetic (phase 1) study of the biliary excretion of AZD0837 and metabolites following a single dose of [3H] AZD0837 given in the duodenum via a Loc-I-Gut catheter to young healthy male subjects
Medical condition
Healthy
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD0837
Sex
Male
Actual Enrollment
8
Study type
Interventional
Age
18 Years - 45 Years
Date
Study Start Date: 01 Jan 2009
Primary Completion Date: -
Study Completion Date: 01 Feb 2009
Study design
Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Other
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Lars Knutson
Inst för Kirurgiska VetenskaperUppsala Universitet
